Risk, returns & timeframes illustration
1 min read
October 18, 2022
by
Belinda Nash

TikTok’s gluttonous grifting 🤤

Gen Zers are making stacks of cash on TikTok. But it took 99-year-old Aunty Beeb to reveal the vertical video app’s greedy gift-grifting - of refugees. And they’re not the only app taking a big slice of creators’ profit pie. Who else is taking ravenous bite-sized chunks out of creators’ revenue?
1 min read
October 18, 2022
by
Belinda Nash

TikTok’s gluttonous grifting 🤤

Gen Zers are making stacks of cash on TikTok. But it took 99-year-old Aunty Beeb to reveal the vertical video app’s greedy gift-grifting - of refugees. And they’re not the only app taking a big slice of creators’ profit pie. Who else is taking ravenous bite-sized chunks out of creators’ revenue?
1 min read
October 18, 2022
by
Belinda Nash

TikTok’s gluttonous grifting 🤤

Gen Zers are making stacks of cash on TikTok. But it took 99-year-old Aunty Beeb to reveal the vertical video app’s greedy gift-grifting - of refugees. And they’re not the only app taking a big slice of creators’ profit pie. Who else is taking ravenous bite-sized chunks out of creators’ revenue?
Table of contents
Getting Started Investing course
Free Getting Started Course
Take your first, or next, step to becoming a confident investor with Hatch's free online course – just 10 minutes a day, for 10 days.

TikTok’s slice of the profit pie may look like grandpa at the buffet, and, well, Aunty Beeb is not impressed. 😒 The BBC last week revealed thirsty TikTok’s near 70% profit take out, which eats into livestreamers’ revenue. The app’s greed was discovered following the broadcaster’s investigation of Syrian refugees asking for money through TikTok LIVE Gifts. 🙏 The BBC found that for US$106 donated, the remaining $33 was split between money transfer agents and TikTok ‘middlemen’, leaving the refugees with just US$19.

But the app’s gorging gift-grifting hasn't seen TikTokers gobbled up by competitor, OnlyFans. The adult subscription service app, designed for ‘celebrities and musicians to monetise their social media following’, lets their 2.1 million creators keep 80% of their subscription earnings - last year divvying up US$4.8 billion between them. 💰

TikTok’s hunger for revenue has, however, turned them into fat cats. Sensor Tower data revealed the Beijing-based app has roasted the competition - including YouTube and Google One (GOOG, GOOGL) - continuing their ‘record-breaking’ streak as the ‘highest grossing app in the world’. 🤳

And TikTok may be cooking up more, adding to last year’s Shopify (SHOP) partnership. The vertical video app is in chats with TalkShopLive - which themselves takes 10% commission from sellers - for live shopping within TikTok’s app. 🛒 Last week Axios also hinted TikTok may be chomping at Amazon’s tail (AMZN), hoping to take a bite out of the US ecommerce market - unwittingly revealed in TikTok Shop job ads. Is Amazon concerned? Who knows. 🤷‍♀️ They own Twitch, which themselves is in a food fight with gamers over the livestreaming app’s gluttonous 70/30 revenue split.

Meanwhile, is Meta hoping for a second bite of the cherry in the meh-taverse? A ‘better looking’ virtual Mark Zuckerberg announced at last week’s Meta Connect 2022 that he’d convinced Microsoft (MSFT) that the future of work is VR. Is this why last year Clippy came out of retirement? 📎

Belinda Nash
Finance writer
Linkedin

We’re not financial advisors and Hatch news is for your information only. However dazzling our writing, none of it is a recommendation to invest in any of the companies or funds mentioned. If you want support before making any investment decisions, consider seeking financial advice from a licensed provider. We’ve done our best to ensure all information is current when we pushed ‘publish’ on this article. And of course, with investing, your money isn’t guaranteed to grow and there’s always a risk you might lose money.

Join the Kiwis who are hatching their tomorrow and have invested more than $1 billion with Hatch.

Explore another series
Tax
Money
Economy
Investing

More recent news articles

Recent learn articles

7 min read
Apr 15, 2025

EV market rising but Tesla sales decline

Predicted by some to become a US $1.58 trillion dollar market globally, in the US alone EV sales are up 11.4% year-over-year. Which countries are leading the fast-charge? And how could trade tariffs impact sales as we accelerate into the second quarter?
Read more
8 min read
Mar 25, 2025

What’s driving gold prices to record highs?

As the world waits for Trump’s tariffs policies to take effect, the allure of gold has sent bullion, stocks and ETFs to glittering highs. But could gold’s volatility and the potential for the US to sell its gold reserves to buy bitcoin prime other global central banks to do the same?
Read more
8 min read
Mar 4, 2025

Can Biotech beat cancer?

Some Kiwi companies are making significant advances in cancer diagnosis and treatment that could save lives worldwide. Global pharmaceutical companies are also making huge strides in cancer clinical trials, but could Trump’s administration derail decades of research?
Read more

Related news articles

More recent learn articles

No items found.

Recent news articles

More recent learn articles

7 min read
Apr 15, 2025

EV market rising but Tesla sales decline

Predicted by some to become a US $1.58 trillion dollar market globally, in the US alone EV sales are up 11.4% year-over-year. Which countries are leading the fast-charge? And how could trade tariffs impact sales as we accelerate into the second quarter?
Read more
8 min read
Mar 25, 2025

What’s driving gold prices to record highs?

As the world waits for Trump’s tariffs policies to take effect, the allure of gold has sent bullion, stocks and ETFs to glittering highs. But could gold’s volatility and the potential for the US to sell its gold reserves to buy bitcoin prime other global central banks to do the same?
Read more
8 min read
Mar 4, 2025

Can Biotech beat cancer?

Some Kiwi companies are making significant advances in cancer diagnosis and treatment that could save lives worldwide. Global pharmaceutical companies are also making huge strides in cancer clinical trials, but could Trump’s administration derail decades of research?
Read more